Current status and future prospect of transcatheter mitral valve replacement

Wenzhi PAN,Daxin ZHOU,Junbo GE

DOI: https://doi.org/10.3969/j.issn.1006-1533.2017.03.003

2017-01-01

Abstract:Transcatheter mitral valve replacement (TMVR) is an interventional surgery compressing the artificial valvein vitro, loading it on delivery system and delivering it to mitral annulus through the vessel or apex to replace valvein situ and is currently only limited to surgical contraindications for exploratory research in patients with mitral regurgitation. TMVR includes four techniques such as valve in valve, valve in ring, valve in native ring, and valve in native valve. In the ifrst three techniques that are relatively mature, the artiifcial valve ring or calciifcation of the valve ring can provide a radial force support and therefore a TMVR procedure can be completed using the current TAVR valve. Autologous mitral valve regurgitation for patients with mitral valve regurgitation but without obvious calciifcation is a true sense of TMVR (the vast majority of mitral valve regurgitation patients suffer from autologous mitral valve regurgitation). The performance of most of the TMVR valve is not satisfactory at present, however the clinical results of Tendyne valve are relatively optimistic. It is expected that TMVR may be an effective treatment for patients with mitral regurgitation who are contraindicated or at high risk for surgery in the near future and however, there are many challenges to be faced before its wide application in clinical practice, especially in patients with mitral regurgitation and relatively low risk of surgical intervention.